CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway
Open Access
- 30 July 2009
- journal article
- Published by Springer Nature in Journal of Inflammation
- Vol. 6 (1) , 22
Abstract
Background: Herpesviruses have evolved chemokines and chemokine receptors, which modulate the recruitment of human leukocytes during the inflammatory response to infection. Early post-infection, human herpesvirus 6A (HHV-6A) infected cells express the chemokine receptor U51A and chemokine U83A which have complementary effects in subverting the CC-chemokine family thereby controlling anti-viral leukocyte recruitment. Here we show that, to potentiate this activity, the viral chemokine can also avoid clearance by scavenger chemokine receptors, DARC and D6, which normally regulate an inflammatory response. Conversely, U83A delays internalisation of its signalling target receptor CCR5 with diversion to caveolin rich membrane domains. This mechanism can redirect displaced human chemokines to DARC and D6 for clearance of the anti-viral inflammatory response, leaving the viral chemokine unchecked.Methods: Cell models for competitive binding assays were established using radiolabeled human chemokines and cold U83A on CCR5, DARC or D6 expressing cells. Flow cytometry was used to assess specific chemotaxis of CCR5 bearing cells to U83A, and internalisation of CCR5 specific chemokine CCL4 after stimulation with U83A. Internalisation analyses were supported by confocal microscopy of internalisation and co-localisation of CCR5 with caveosome marker caveolin-1, after virus or human chemokine stimulation.Results: U83A displaced efficiently human chemokines from CCR5, with a high affinity of 0.01nM, but not from DARC or D6. Signalling via CCR5 resulted in specific chemoattraction of primary human leukocytes bearing CCR5. However, U83A effective binding and signalling to CCR5 resulted in delayed internalisation and recycling up to 2 hours in the absence of continual re-stimulation. This resulted in diversion to a delayed caveolin-linked pathway rather than the rapid clathrin mediated endocytosis previously shown with human chemokines CCL3 or CCL4.Conclusion: U83A diverts human chemokines from signalling, but not regulatory or scavenger, receptors facilitating their clearance, while occupying signalling receptors at the cell surface. This can enhance virus specific inflammation, facilitating dissemination to replication sensitive leukocytes while evading clearance; this has implications for linked neuro-inflammatory pathologies.Keywords
This publication has 53 references indexed in Scilit:
- Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infectionBrain and Development, 2009
- The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activityNature Immunology, 2008
- Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infectionTransplant International, 2008
- Orchestrating the orchestrators: chemokines in control of T cell trafficNature Immunology, 2008
- Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibodyJournal of Molecular and Cellular Cardiology, 2007
- Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Proceedings of the National Academy of Sciences, 2007
- Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalizationBlood, 2007
- Ligand-Induced Partitioning of Human CXCR1 Chemokine Receptors with Lipid Raft Microenvironments Facilitates G-Protein-Dependent SignalingMolecular and Cellular Biology, 2005
- Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7)The Journal of Pediatrics, 2004
- HHV-6 infection during pregnancy and spontaneous abortionThe Lancet, 1992